| Product Code: ETC12838572 | Publication Date: Apr 2025 | Updated Date: Feb 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Sri Lanka import trend for influenza medications saw a significant growth rate of 43.03% from 2023 to 2024, with a compound annual growth rate (CAGR) of 17.08% from 2020 to 2024. This surge in imports can be attributed to increased demand for pharmaceutical products in response to public health concerns.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sri Lanka Influenza Medications Market Overview |
3.1 Sri Lanka Country Macro Economic Indicators |
3.2 Sri Lanka Influenza Medications Market Revenues & Volume, 2022 & 2032F |
3.3 Sri Lanka Influenza Medications Market - Industry Life Cycle |
3.4 Sri Lanka Influenza Medications Market - Porter's Five Forces |
3.5 Sri Lanka Influenza Medications Market Revenues & Volume Share, By Drug Type, 2022 & 2032F |
3.6 Sri Lanka Influenza Medications Market Revenues & Volume Share, By Route of Administration, 2022 & 2032F |
3.7 Sri Lanka Influenza Medications Market Revenues & Volume Share, By Patient Age Group, 2022 & 2032F |
4 Sri Lanka Influenza Medications Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of influenza in Sri Lanka |
4.2.2 Growing awareness about the importance of early treatment for influenza |
4.2.3 Government initiatives to improve healthcare infrastructure and access to medications |
4.3 Market Restraints |
4.3.1 High cost of influenza medications |
4.3.2 Limited availability of advanced influenza treatment options in Sri Lanka |
5 Sri Lanka Influenza Medications Market Trends |
6 Sri Lanka Influenza Medications Market, By Types |
6.1 Sri Lanka Influenza Medications Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sri Lanka Influenza Medications Market Revenues & Volume, By Drug Type, 2022 - 2032F |
6.1.3 Sri Lanka Influenza Medications Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Peramivir, Baloxavir), 2022 - 2032F |
6.1.4 Sri Lanka Influenza Medications Market Revenues & Volume, By Symptom Relief Medications (Pain Relievers, Decongestants, Antihistamines), 2022 - 2032F |
6.2 Sri Lanka Influenza Medications Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Sri Lanka Influenza Medications Market Revenues & Volume, By Oral, 2022 - 2032F |
6.2.3 Sri Lanka Influenza Medications Market Revenues & Volume, By Intravenous (IV), 2022 - 2032F |
6.2.4 Sri Lanka Influenza Medications Market Revenues & Volume, By Inhalation, 2022 - 2032F |
6.3 Sri Lanka Influenza Medications Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Sri Lanka Influenza Medications Market Revenues & Volume, By Pediatric, 2022 - 2032F |
6.3.3 Sri Lanka Influenza Medications Market Revenues & Volume, By Adult, 2022 - 2032F |
6.3.4 Sri Lanka Influenza Medications Market Revenues & Volume, By Geriatric, 2022 - 2032F |
7 Sri Lanka Influenza Medications Market Import-Export Trade Statistics |
7.1 Sri Lanka Influenza Medications Market Export to Major Countries |
7.2 Sri Lanka Influenza Medications Market Imports from Major Countries |
8 Sri Lanka Influenza Medications Market Key Performance Indicators |
8.1 Number of influenza cases reported annually in Sri Lanka |
8.2 Percentage of population vaccinated against influenza |
8.3 Average waiting time for influenza medication prescription and dispensing at healthcare facilities |
9 Sri Lanka Influenza Medications Market - Opportunity Assessment |
9.1 Sri Lanka Influenza Medications Market Opportunity Assessment, By Drug Type, 2022 & 2032F |
9.2 Sri Lanka Influenza Medications Market Opportunity Assessment, By Route of Administration, 2022 & 2032F |
9.3 Sri Lanka Influenza Medications Market Opportunity Assessment, By Patient Age Group, 2022 & 2032F |
10 Sri Lanka Influenza Medications Market - Competitive Landscape |
10.1 Sri Lanka Influenza Medications Market Revenue Share, By Companies, 2025 |
10.2 Sri Lanka Influenza Medications Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here